Puma Biotechnology (PBYI) Net Cash Flow (2011 - 2026)
Puma Biotechnology (PBYI) posted Net Cash Flow of $6.6 million for Q1 2026, up 127.45% on a QoQ basis from -$23.9 million in Q4 2025, and up 205.96% year-over-year from $2.1 million in Q1 2025.
Puma Biotechnology (PBYI) Net Cash Flow (2011 - 2026) Analysis & Trends
Puma Biotechnology's Net Cash Flow history runs 16 years deep, the most recent figure standing at $6.6 million for Q1 2026.
- Quarterly Net Cash Flow rose 205.96% year-over-year to $6.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$26.8 million (down 95.59% YoY) and the FY2025 annual result came in at -$39.6 million, down 157.61% from the prior year.
- Net Cash Flow was $6.6 million for Q1 2026 at Puma Biotechnology, up from -$23.9 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $25.2 million in Q3 2022 and bottomed at -$23.9 million in Q4 2025.
- A 5-year average of -$2.2 million and a median of -$1.8 million in 2022 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow surged 229.9% — and 2025, when it plunged 1321.37%.
- Puma Biotechnology's Net Cash Flow stood at -$1.8 million in 2022, then jumped by 229.9% to $2.3 million in 2023, then declined by 14.4% to $2.0 million in 2024, then plunged by 1321.37% to -$23.9 million in 2025, then soared by 127.45% to $6.6 million in 2026.
- Business Quant data shows PBYI's Net Cash Flow at $6.6 million in Q1 2026, -$23.9 million in Q4 2025, and -$1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 224.46 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn | 6.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.56 Mn |
| Mar 31, 2026 | 6.56 Mn |
| Dec 31, 2025 | -23.89 Mn |
| Dec 31, 2025 | -23.89 Mn |
| Sep 30, 2025 | -1.14 Mn |
| Sep 30, 2025 | -1.14 Mn |
| Jun 30, 2025 | -8.37 Mn |
| Jun 30, 2025 | -8.37 Mn |
| Mar 31, 2025 | -6.19 Mn |
| Mar 31, 2025 | -6.19 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Dec 31, 2024 | 1.96 Mn |
| Sep 30, 2024 | 114,000.00 |
| Sep 30, 2024 | 114,000.00 |
| Jun 30, 2024 | -9.60 Mn |
| Jun 30, 2024 | -9.60 Mn |
| Mar 31, 2024 | -7.83 Mn |
| Mar 31, 2024 | -7.83 Mn |
| Dec 31, 2023 | 2.29 Mn |
| Dec 31, 2023 | 2.29 Mn |